Marchex Closes Archenia Deal, Projects $60M Revenue and 10%+ EBITDA Margins
MCHX sits 36% above its 52-week low of $1.322.
Summary
Marchex completed its acquisition of Archenia on July 16, combining assets that target a $60M annual revenue run rate with 15–20% growth and adjusted EBITDA margins above 10% in 2026. This follows the July 1 announcement of the deal closing and adds concrete financial projections that were not previously disclosed. The $60M revenue target represents a significant scale-up for Marchex, which reported $12.7M in Q1 revenue, and the margin guidance suggests the combined entity will be profitable at the EBITDA level. The deal was funded with $10M in convertible notes and up to 4M shares, which could be dilutive but the growth outlook may offset that concern. Watch for Q2 earnings to see if the integration is on track and if the company reaffirms these targets.
At the time of this announcement, MCHX was trading at $1.80 on NASDAQ in the Technology sector, with a market capitalization of approximately $79.8M. The 52-week trading range was $1.32 to $2.14. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.